Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Nucleic Acids Research

Volumn 40, Issue D1, 2012, Pages

  Caputo, Sandrine ^a   Benboudjema, Louisa ^a   Sinilnikova, Olga ^b,c   Rouleau, Etienne ^a   Béroud, Christophe ^a   Lidereau, Rosette ^d,e,f   Sevenet, Nicolas ^g   Bonnet, Françoise ^g   Longy, Michel ^g   Hardouin, Agnès ^h   Vaur, Dominique ^h   Krieger, Sophie ^h   Uhrhammer, Nancy ⁱ   Bignon, Yves Jean ⁱ   Peyrat, Jean Philippe ^j   Revillion, Françoise ^j   Fournier, Jöelle ^j   Remenieras, Audrey ^k,l   Mazoyer, Sylvie ^k   Léone, Mélanie ^b   Sobol, Hagay ^l   Noguchi, Tetsuro ^l   Bourdon, Violaine ^l   Rey, Jean Marc ^e   Bronner, Myriam ^m   Jonveaux, Philippe ^m   Philippe, Christophe ^m   Delnatte, Capucine ⁿ   Coulet, Florence ^o   Castera, Laurent ^a   Caux Moncoutier, Virginie ^a   Houdayer, Claude ^a   Stoppa Lyonnet, Dominique ^a   Delvincourt, Chantal ^p   Gorisse, Marie Claude ^p   Bièche, Ivan ^a   Lefol, Cédrick ^a   Muller, Danièle ^q   Abecassis, Joseph ^q   Toulas, Christine ^r   Guillaud Bataille, Marine ^s   Paillerets, Brigitte Bressac De ^s   more..

^a INSTITUT CURIE   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSERM   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

^f UNIV MONTPELLIER   (France)

^g INSTITUT BERGONIÉ   (France)

^h CENTRE FRANÇOIS BACLESSE   (France)

ⁱ CENTRE JEAN PERRIN   (France)

^j CENTRE OSCAR LAMBRET   (France)

^k CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^l INSTITUT PAOLI CALMETTES   (France)

^m CHU NANCY BRABOIS   (France)

ⁿ HÔTEL DIEU   (France)

^o ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^p INSTITUT JEAN GODINOT   (France)

^q CENTRE PAUL STRAUSS   (France)

^r INSTITUT CLAUDIUS REGAUD   (France)

^s INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ALGORITHM; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLASSIFICATION; CONTROLLED STUDY; ETHNIC GROUP; EXON; FAMILIAL CANCER; FRANCE; FRENCH LANGUAGE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; ONCOGENE; OVARY CANCER; PATHOGENICITY; PRIORITY JOURNAL;

BREAST NEOPLASMS; DATABASES, NUCLEIC ACID; FEMALE; FRANCE; GENES, BRCA1; GENES, BRCA2; GENETIC VARIATION; HUMANS; MUTATION; OVARIAN NEOPLASMS; SOFTWARE;

EID: 84862173376     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1160     Document Type: Article

References (61)

1. Mazoyer,S. (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum. Mutat., 25, 415-422.
2. Sluiter,M.D. and van Rensburg,E.J. (2010) Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res. Treat, 125, 325-349.
3. INCa. (2010) Consultations et Laboratoires. Institut National du Cancer, Boulogne-Billancourt.
4. Ware,M.D., DeSilva,D., Sinilnikova,O.M., Stoppa-Lyonnet,D., Tavtigian,S.V. and Mazoyer,S. (2006) Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? Oncogene, 25, 323-328. (Pubitemid 43083695)
5. Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa- Lyonnet,D., Sinilnikova,O.M. and Mazoyer,S. (2008) Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? Hum. Mutat., 29, 65-73.
6. Caux-Moncoutier,V., Pages-Berhouet,S., Michaux,D., Asselain,B., Castera,L., De Pauw,A., Buecher,B., Gauthier-Villars,M., Stoppa-Lyonnet,D. and Houdayer,C. (2009) Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet., 17, 1471-1480.
7. Chen,X., Truong,T.T., Weaver,J., Bove,B.A., Cattie,K., Armstrong,B.A., Daly,M.B. and Godwin,A.K. (2006) Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum. Mutat., 27, 427-435. (Pubitemid 43673329)
8. Carvalho,M.A., Marsillac,S.M., Karchin,R., Manoukian,S., Grist,S., Swaby,R.F., Urmenyi,T.P., Rondinelli,E., Silva,R., Gayol,L. et al. (2007) Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res., 67, 1494-1501. (Pubitemid 46383373)
9. Sinilnikova,O.M., Mazoyer,S., Bonnardel,C., Lynch,H.T., Narod,S.A. and Lenoir,G.M. (2006) BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families. Fam. Cancer, 5, 15-20. (Pubitemid 43384315)
10. Morris,J.R., Pangon,L., Boutell,C., Katagiri,T., Keep,N.H. and Solomon,E. (2006) Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum. Mol. Genet., 15, 599-606. (Pubitemid 43205424)
11. Goldgar,D.E., Easton,D.F., Byrnes,G.B., Spurdle,A.B., Iversen,E.S. and Greenblatt,M.S. (2008) Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum. Mutat., 29, 1265-1272.
12. Goldgar,D.E., Easton,D.F., Deffenbaugh,A.M., Monteiro,A.N., Tavtigian,S.V. and Couch,F.J. (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am. J. Hum. Genet., 75, 535-544. (Pubitemid 39244769)
13. Lee,E., McKean-Cowdin,R., Ma,H., Chen,Z., Van Den Berg,D., Henderson,B.E., Bernstein,L. and Ursin,G. (2008) Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients. Breast Cancer Res., 10, R19.
14. Judkins,T., Hendrickson,B.C., Deffenbaugh,A.M., Eliason,K., Leclair,B., Norton,M.J., Ward,B.E., Pruss,D. and Scholl,T. (2005) Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res., 65, 10096-10103. (Pubitemid 41541492)
15. Couch,F.J., Rasmussen,L.J., Hofstra,R., Monteiro,A.N., Greenblatt,M.S. and de Wind,N. (2008) Assessment of functional effects of unclassified genetic variants. Hum. Mutat., 29, 1314-1326.
16. Fleming,M.A., Potter,J.D., Ramirez,C.J., Ostrander,G.K. and Ostrander,E.A. (2003) Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc. Natl Acad. Sci. USA, 100, 1151-1156. (Pubitemid 36183971)
17. Frederic,M.Y., Lalande,M., Boileau,C., Hamroun,D., Claustres,M., Beroud,C. and Collod-Beroud,G. (2009) UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity - application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Hum. Mutat., 30, 952-959.
18. Szabo,C., Masiello,A., Ryan,J.F. and Brody,L.C. (2000) The breast cancer information core: database design, structure, and scope. Hum. Mutat., 16, 123-131. (Pubitemid 30604901)
19. Fokkema,I.F., den Dunnen,J.T. and Taschner,P.E. (2005) LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach. Hum. Mutat., 26, 63-68. (Pubitemid 41040673)
20. Osborne,R.H., Hopper,J.L., Kirk,J.A., Chenevix-Trench,G., Thorne,H.J. and Sambrook,J.F. (2000) kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med. J. Aust., 172, 463-464.
21. Tan,E.C., Loh,M., Chuon,D. and Lim,Y.P. (2006) Singapore human mutation/polymorphism database: a country-specific database for mutations and polymorphisms in inherited disorders and candidate gene association studies. Hum. Mutat., 27, 232-235.
22. Cooper,D.N., Stenson,P.D. and Chuzhanova,N.A. (2006) The human gene mutation database (HGMD) and its exploitation in the study of mutational mechanisms. Curr. Protoc. Bioinformatics, Chapter 1, Unit 1 13.
23. Beroud,C., Hamroun,D., Collod-Beroud,G., Boileau,C., Soussi,T. and Claustres,M. (2005) UMD (Universal Mutation Database): 2005 update. Hum. Mutat., 26, 184-191. (Pubitemid 41254373)
24. Beroud,C., Collod-Beroud,G., Boileau,C., Soussi,T. and Junien,C. (2000) UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum. Mutat., 15, 86-94. (Pubitemid 30036174)
25. Cotton,R.G., Auerbach,A.D., Beckmann,J.S., Blumenfeld,O.O., Brookes,A.J., Brown,A.F., Carrera,P., Cox,D.W., Gottlieb,B., Greenblatt,M.S. et al. (2008) Recommendations for locus-specific databases and their curation. Hum. Mutat., 29, 2-5.
26. Eisinger,F., Alby,N., Bremond,A., Dauplat,J., Espie,M., Janiaud,P., Kuttenn,F., Lebrun,J.P., Lefranc,J.P., Pierret,J. et al. (1999) Inserm ad hoc committee: recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary. Bull. Cancer, 86, 307-313. (Pubitemid 29196092)
27. Plon,S.E., Eccles,D.M., Easton,D., Foulkes,W.D., Genuardi,M., Greenblatt,M.S., Hogervorst,F.B., Hoogerbrugge,N., Spurdle,A.B. and Tavtigian,S.V. (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat., 29, 1282-1291.
28. Schouten,J.P., McElgunn,C.J., Waaijer,R., Zwijnenburg,D., Diepvens,F. and Pals,G. (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res., 30, e57.
29. Casilli,F., Di Rocco,Z.C., Gad,S., Tournier,I., Stoppa-Lyonnet,D., Frebourg,T. and Tosi,M. (2002) Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum. Mutat., 20, 218-226. (Pubitemid 34966850)
30. Barrois,M., Bieche,I., Mazoyer,S., Champeme,M.H., Bressac-de Paillerets,B. and Lidereau,R. (2004) Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families. Clin. Genet., 65, 131-136. (Pubitemid 38220114)
31. Rouleau,E., Lefol,C., Bourdon,V., Coulet,F., Noguchi,T., Soubrier,F., Bieche,I., Olschwang,S., Sobol,H. and Lidereau,R. (2009) Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome. Hum. Mutat., 30, 867-875.
32. Weber,J., Miserere,S., Champ,J., Looten,R., Stoppa-Lyonnet,D., Viovy,J.L. and Houdayer,C. (2007) High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE. Electrophoresis, 28, 4282-4288. (Pubitemid 350259029)
33. Gad,S., Aurias,A., Puget,N., Mairal,A., Schurra,C., Montagna,M., Pages,S., Caux,V., Mazoyer,S., Bensimon,A. et al. (2001) Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer, 31, 75-84. (Pubitemid 32274135)
34. Rouleau,E., Lefol,C., Tozlu,S., Andrieu,C., Guy,C., Copigny,F., Nogues,C., Bieche,I. and Lidereau,R. (2007) High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1. Clin. Genet., 72, 199-207. (Pubitemid 47300022)
35. Tavtigian,S.V., Deffenbaugh,A.M., Yin,L., Judkins,T., Scholl,T., Samollow,P.B., de Silva,D., Zharkikh,A. and Thomas,A. (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J. Med. Genet., 43, 295-305.
36. Ng,P.C. and Henikoff,S. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814. (Pubitemid 37442253)
37. Ramensky,V., Bork,P. and Sunyaev,S. (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res., 30, 3894-3900. (Pubitemid 35012462)
38. Stoppa-Lyonnet,D., Laurent-Puig,P., Essioux,L., Pages,S., Ithier,G., Ligot,L., Fourquet,A., Salmon,R.J., Clough,K.B., Pouillart,P. et al. (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am. J. Hum. Genet., 60, 1021-1030. (Pubitemid 27194086)
39. Muller,D., Bonaiti-Pellie,C., Abecassis,J., Stoppa-Lyonnet,D. and Fricker,J.P. (2004) BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect. Fam. Cancer, 3, 15-20. (Pubitemid 40655349)
40. Hall,M.J., Reid,J.E., Burbidge,L.A., Pruss,D., Deffenbaugh,A.M., Frye,C., Wenstrup,R.J., Ward,B.E., Scholl,T.A. and Noll,W.W. (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer, 115, 2222-2233.
41. Suzuki,K., Iwata,M., Tsuji,H., Takagi,T., Tamura,A., Ishimoto,G., Ito,S., Matsui,K. and Miyazaki,T. (1997) A de novo recombination in the ABO blood group gene and evidence for the occurence of recombination products. Hum. Genet., 99, 454-461. (Pubitemid 27152092)
42. Diez,O., Osorio,A., Duran,M., Martinez-Ferrandis,J.I., de la Hoya,M., Salazar,R., Vega,A., Campos,B., Rodriguez-Lopez,R., Velasco,E. et al. (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum. Mutat., 22, 301-312. (Pubitemid 37210855)
43. Machado,P.M., Brandao,R.D., Cavaco,B.M., Eugenio,J., Bento,S., Nave,M., Rodrigues,P., Fernandes,A. and Vaz,F. (2007) Screening for a BRCA2 rearrangement in high-risk breast/ ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J. Clin. Oncol., 25, 2027-2034. (Pubitemid 46972787)
44. Petrij-Bosch,A., Peelen,T., van Vliet,M., van Eijk,R., Olmer,R., Drusedau,M., Hogervorst,F.B., Hageman,S., Arts,P.J., Ligtenberg,M.J. et al. (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet., 17, 341-345. (Pubitemid 27476002)
45. Palomba,G., Pisano,M., Cossu,A., Budroni,M., Dedola,M.F., Farris,A., Contu,A., Baldinu,P., Tanda,F. and Palmieri,G. (2005) Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening. Cancer, 104, 1172-1179. (Pubitemid 41278951)
46. Hohenstein,P., Kielman,M.F., Breukel,C., Bennett,L.M., Wiseman,R., Krimpenfort,P., Cornelisse,C., van Ommen,G.J., Devilee,P. and Fodde,R. (2001) A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. Oncogene, 20, 2544-2550. (Pubitemid 32531351)
47. Gowen,L.C., Johnson,B.L., Latour,A.M., Sulik,K.K. and Koller,B.H. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet., 12, 191-194. (Pubitemid 26051301)
48. Evers,B. and Jonkers,J. (2006) Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene, 25, 5885-5897. (Pubitemid 44453444)
49. Howlett,N.G., Taniguchi,T., Olson,S., Cox,B., Waisfisz,Q., De Die-Smulders,C., Persky,N., Grompe,M., Joenje,H., Pals,G. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609. (Pubitemid 34815345)
50. Alter,B.P., Rosenberg,P.S. and Brody,L.C. (2007) Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J. Med. Genet., 44, 1-9. (Pubitemid 46142832)
51. Ludwig,T., Chapman,D.L., Papaioannou,V.E. and Efstratiadis,A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/ Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev., 11, 1226-1241. (Pubitemid 27235356)
52. Leegte,B., van der Hout,A.H., Deffenbaugh,A.M., Bakker,M.K., Mulder,I.M., ten Berge,A., Leenders,E.P., Wesseling,J., de Hullu,J., Hoogerbrugge,N. et al. (2005) Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J. Med. Genet., 42, e20.
53. Simard,J., Dumont,M., Moisan,A.M., Gaborieau,V., Malouin,H., Durocher,F., Chiquette,J., Plante,M., Avard,D., Bessette,P. et al. (2007) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J. Med. Genet., 44, 107-121.
54. Williams,R.S., Green,R. and Glover,J.N. (2001) Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol., 8, 838-842. (Pubitemid 32923600)
55. Shiozaki,E.N., Gu,L., Yan,N. and Shi,Y. (2004) Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell, 14, 405-412. (Pubitemid 38591411)
56. Yang,H., Jeffrey,P.D., Miller,J., Kinnucan,E., Sun,Y., Thoma,N.H., Zheng,N., Chen,P.L., Lee,W.H. and Pavletich,N.P. (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science, 297, 1837-1848. (Pubitemid 35024337)
57. Karchin,R., Monteiro,A.N., Tavtigian,S.V., Carvalho,M.A. and Sali,A. (2007) Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput. Biol., 3, e26.
58. Vallon-Christersson,J., Cayanan,C., Haraldsson,K., Loman,N., Bergthorsson,J.T., Brondum-Nielsen,K., Gerdes,A.M., Moller,P., Kristoffersson,U., Olsson,H. et al. (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum. Mol. Genet., 10, 353-360. (Pubitemid 32166546)
59. Williams,R.S., Chasman,D.I., Hau,D.D., Hui,B., Lau,A.Y. and Glover,J.N. (2003) Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J. Biol. Chem., 278, 53007-53016. (Pubitemid 38035903)
60. Nikolopoulos,G., Pyrpassopoulos,S., Thanassoulas,A., Klimentzou,P., Zikos,C., Vlassi,M., Vorgias,C.E., Yannoukakos,D. and Nounesis,G. (2007) Thermal unfolding of human BRCA1 BRCT-domain variants. Biochim. Biophys. Acta, 1774, 772-780. (Pubitemid 46863413)
61. Karchin,R., Agarwal,M., Sali,A., Couch,F. and Beattie,M.S. (2008) Classifying variants of undetermined significance in BRCA2 with protein likelihood ratios. Cancer Inform., 6, 203-216.